Striatal DRD2 decline

Biomarker

1 paper1 finding

  • Humans1

Associations

1

Confluent white-matter lesions and lacunes

upin humans1

1 study
  1. Confluent white-matter lesions and lacunes predict striatal DRD2 decline in humans (DRD2 change: approximately −4% with both manifestations, −2% with one, and 0% with neither).

    “Manifestations of confluent lesions and lacunes at baseline had additive effects on DRD2 decline.”

    Humanshealthy older adultsstriatum5 yearsn = 129

    Cerebral small-vessel disease severity, hypertension, and body mass index forecast striatal dopamine D2-receptor decline rates in aging

    Neurobiology of aging6 Aug 2025

More on Confluent white-matter lesions and lacunes

Latest